SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000920465-17-000087
Filing Date
2017-12-29
Accepted
2017-12-29 16:31:13
Documents
15
Period of Report
2017-12-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k2017decemberpresentati.htm 8-K 21844
2 EXHIBIT 99.1 lajollapharmaceuticalcom.htm EX-99.1 15142
3 lajollapharmaceuticalcom001.jpg GRAPHIC 65291
4 lajollapharmaceuticalcom002.jpg GRAPHIC 249715
5 lajollapharmaceuticalcom003.jpg GRAPHIC 192845
6 lajollapharmaceuticalcom004.jpg GRAPHIC 77017
7 lajollapharmaceuticalcom005.jpg GRAPHIC 133441
8 lajollapharmaceuticalcom006.jpg GRAPHIC 137331
9 lajollapharmaceuticalcom007.jpg GRAPHIC 111722
10 lajollapharmaceuticalcom008.jpg GRAPHIC 112832
11 lajollapharmaceuticalcom009.jpg GRAPHIC 253906
12 lajollapharmaceuticalcom010.jpg GRAPHIC 113951
13 lajollapharmaceuticalcom011.jpg GRAPHIC 110849
14 lajollapharmaceuticalcom012.jpg GRAPHIC 121285
15 lajollapharmaceuticalcom013.jpg GRAPHIC 37189
  Complete submission text file 0000920465-17-000087.txt   2385668
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 171282263
SIC: 2836 Biological Products, (No Diagnostic Substances)